News provided by Eli Lilly and Company Dec 11, 2025, 06:45 ET In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function, with more than 1 out of 8 retatrutide-treated patients completely free from knee pain at the end of the trial Seven additional Phase 3 trials evaluating the investigational once-weekly treatment in obesity and type 2 diabetes are expected to complete in 2026 INDIANAPOLIS, Dec
Equally important is hydration and micronutrient balance
For NAFLD-specific monitoring, patients with established liver disease may require additional specialist hepatology input, including non-invasive fibrosis assessment and consideration for liver imaging
Marketed under the name LBM LBM GLP 1 Nano Microneedle Patch , it promises quick weight lossup to 20 pounds in weekswhile appearing endorsed by top institutions such as Stanford Medicine and using official-sounding labels like FDA Approved and GMP Certified. But is this too good to be true
Some studies suggest Ozempic may increase sex drive in some men, while others say it could decrease sex drive